New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2014
07:53 EDTCRMECardiome's Brinavess shows positive results in cardiological study
Cardiome announced that an independent, investigator-led investigation demonstrated real-world cardioversion experience with Brinavess RINAVESS (vernakalant IV) in patients who developed post-cardiac surgery atrial fibrillation. This was a prospective, non-randomised, single-arm study in 50 patients. The primary outcome was the conversion of atrial fibrillation to sinus rhythm 90 minutes post-Brinavess RINAVESS infusion. Brinavess was successful in cardioverting 74% of the patients.
News For CRME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 24, 2015
08:03 EDTCRMECardiome expands commercialization partnership with Eddingpharm
Cardiome announced that its subsidiary, Correvio International Sarl, has entered into an exclusive license and supply agreement with Eddingpharm to distribute and commercialize AGGRASTAT in China. Financial terms of the agreement include milestone payments and minimum annual commercial commitments. The financial terms of the agreement are not disclosed.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use